Skip to main content
XTL Biopharmaceuticals Ltd. logo

XTL Biopharmaceuticals Ltd. — Investor Relations & Filings

Ticker · XTLB ISIN · IL0010854979 LEI · 529900NDDXEAPTUTXP41 TA Manufacturing
Open in API
Filings indexed 1,223 across all filing types
Latest filing 2018-12-27 Declaration of Voting R…
Country IL Israel
Listing TA XTLB

About XTL Biopharmaceuticals Ltd.

https://www.xtlbio.com

XTL Biopharmaceuticals Ltd. is a clinical-stage biopharmaceutical company focused on the acquisition and development of pharmaceutical products to address unmet clinical needs. The company's primary therapeutic area of interest is autoimmune diseases. Its development pipeline has included proprietary drug candidates for conditions such as Systemic Lupus Erythematosus (SLE).

Recent filings

Filing Released Lang Actions
REPORT OF FOREIGN PRIVATE ISSUER
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a Form 6-K filed by a foreign private issuer, XTL Biopharmaceuticals Ltd., reporting the results of its Annual General Meeting held on December 27, 2018. The content includes resolutions passed at the AGM such as re-appointment of auditors and election of directors. The document is relatively short (3921 characters) and primarily announces the outcomes of the shareholder meeting rather than providing detailed financial statements or comprehensive reports. This fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA), which covers official results from shareholder votes at general meetings. There is no indication that this is the full Annual Report or other detailed financial filings. Therefore, the correct classification is DVA with high confidence.
2018-12-27 English
Immediate Report of Meeting
AGM Information Classification · 95% confidence The document is explicitly titled 'Form 6-K, Report of Foreign Private Issuer' filed with the SEC for the month of December 2018. Form 6-K is used by foreign private issuers to report material information not required to be reported under the home country's requirements or to furnish information to the SEC. The content announces the postponement of the 'annual shareholders' meeting'. While it relates to an AGM, the filing itself is a Form 6-K, which is a general regulatory filing mechanism for foreign private issuers. Since 'Form 6-K' does not map directly to a specific category like 10-K or DEF 14A, and it is a mandatory regulatory submission reporting a material event (postponement of AGM), the most appropriate general classification among the provided options is 'Regulatory Filings' (RNS), as it is a catch-all for SEC filings that don't fit the specialized categories. However, since the core event is the postponement of the Annual Shareholders' Meeting, and AGM-R covers AGM materials, RNS is the best fit for the *filing type* itself (Form 6-K). Given the options, RNS is the most accurate classification for a Form 6-K filing.
2018-12-20 English
Immediate Report of Meeting
AGM Information Classification · 98% confidence The document explicitly states it is an 'Immediate Report of Meeting' and concerns the 'postponement of meeting' from 20/12/2018 to 27/12/2018. The agenda items discuss the auditor's report and the re-election of directors, which are typical items for an Annual General Meeting (AGM). Since this document is a notification regarding the scheduling and agenda of a meeting, and specifically mentions the 'annual meeting', it aligns best with the AGM Information category (AGM-R). It is not the final voting results (DVA) nor the presentation materials (IP), but the notice/postponement related to the AGM itself.
2018-12-20 English
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings Classification · 95% confidence The document is a Form 6-K filed by a foreign private issuer, XTL Biopharmaceuticals Ltd., with the SEC. It announces the postponement of the annual shareholders' meeting due to lack of quorum and provides details about the rescheduled meeting date. The document is short (3026 characters) and primarily serves as an announcement rather than a detailed report. It does not contain financial statements or substantive financial data. The content focuses on meeting scheduling and shareholder information, not on financial results or management discussion. Therefore, it is best classified as a Regulatory Filing (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2018-12-20 English
Immediate Report of Meeting
AGM Information Classification · 98% confidence The document is explicitly titled 'FORM 6-K' and is filed 'For the Month of November 2018'. The content details the announcement of an 'Annual General Meeting of Shareholders' scheduled for December 20, 2018, and furnishes the associated 'Notice and Proxy Statement' and 'Proxy Card'. The core purpose of this filing is to provide notice and materials related to soliciting shareholder votes for the AGM. This aligns perfectly with the definition of materials shared during or in preparation for an Annual General Meeting (AGM-R). Although it contains a Proxy Statement (which might suggest PSI), the context is the official filing announcing the AGM and attaching the proxy materials, making AGM-R the most appropriate primary classification for this Form 6-K submission.
2018-11-15 English
Immediate Report of Meeting
AGM Information Classification · 98% confidence The document explicitly states it is an 'Immediate Report of Meeting' and details the 'convening of meeting' for an 'annual meeting' scheduled for 20/12/2018. The agenda items include discussing the auditor's report and re-electing directors, which are typical items for an Annual General Meeting (AGM). This content aligns perfectly with the definition of AGM Information (AGM-R), which covers presentations and materials shared during the AGM, or potentially a precursor notice. Since it details the convening and agenda of the AGM, AGM-R is the most appropriate classification over a general Regulatory Filing (RNS) or a Proxy Solicitation (PSI), as it is specifically about the meeting itself.
2018-11-15 English

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.